← Explore · Market KXFDAAPPROVE-MDMA-32JAN01
Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2032?
55.5% implied · bid 52.0¢ · ask 59.0¢
☆ Log in to trackA · Price & probability
The market prices this at 51.0%, up 26.0pt over 24h, on a 7.0¢ spread.
Implied probability51.0%
Bid / ask / mid52.0¢ / 59.0¢ / 55.5¢
Spread7.0¢ (12.6%)
Change 24h+26.00pt
Change 7d+1.00pt
B · Liquidity & flow
Thin (score 15/100) — trade small; large orders will move the price. Order book leans 18% to the ask (sellers).
Volume 24h$0
Depth ±5¢ (bid/ask)$258 / $298
Imbalance18% bid
Large trades (>$1k)0
Liquidity score15.3 / 100
C · Momentum & volatility
RSI 50 (neutral); price is below its 7-day mean by 0.9σ — normal range.
Z-score vs 7d mean-0.89
RSI (14, hourly)50.3
Realized vol 7d4.73pt
Change 1h+0.00pt
E · Time & structure
Resolves in 1945d 6h.
Time to resolve1945d 6h
Resolution sourcemanual-review
Sum of outcomes100.0%